Market Overview:
The global DNA modifying agents market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for genomic research, gene therapy, and cancer research. Additionally, the increasing use of DNA modifying agents in drug development is also contributing to the growth of the market. However, stringent regulatory norms may restrain the growth of this market during the forecast period.
Product Definition:
DNA modifying agents are chemicals that can change the structure of DNA. This can either be done to change the way a gene functions, or to add or remove genetic material. DNA modifying agents are important because they can be used to treat genetic disorders, or to create genetically modified organisms.
Cross-linkers:
The cross-linkers are the chemical entities that cause the polymerization of nucleic acids. Cross-linkers find applications in DNA modifying agents, restriction enzymes, and ligases. The global market for cross-linkers is expected to witness significant growth over the forecast period owing to its increasing demand in DNA modifying agents and restriction enzymes used for genome editing purposes.
Enzymes:
Enzymes are protein catalysts that act as cellular workhorses for various reactions in the body. They are used by DNA modifying agents to carry out their task of modifying genetic material. The enzymes market is expected to witness growth over the forecast period owing to its increasing application in research and development (R&D) activities related to biotechnology, pharmaceuticals, and medical industries.
Application Insights:
The other applications segment includes agriculture and environment. The use of these agents in the field of agriculture is expected to witness significant growth over the forecast period owing to rising awareness among farmers regarding crop modification. Genomic research is anticipated to be the fastest growing application segment due to increasing government funding for genetic research and an increase in R&D activities pertaining to plant breeding.
Increasing demand for food crops that provide nutritional benefits along with enhanced resistance against diseases, pests, and abiotic stresses is expected drive market growth over the forecast period. DNA modifying techniques have also been used for producing plants with increased yield as well as improved quality such as longer shelf life, larger size, better taste etcetera (OECD Agriculture statistics). These factors are projected to augment industry expansion during the study period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of several research entities and universities that are engaged in genomic studies. Moreover, government funding for such projects is another factor boosting the regional market growth. For instance, according to a study published by National Institutes of Health (NIH), between 2007 and 2014, more than 1 million dollars were provided for genome editing research at NIH’s Janelia Farm Research Campus alone during this period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing investments from private companies as well as public agencies towards R&D activities related to DNA modification techniques used in various applications including agriculture and medicine. In addition, growing awareness about these technologies among farmers will drive this regional market further.
Growth Factors:
- Increasing demand for precision medicine
- Rising prevalence of cancer and other genetic disorders
- Technological advancements in DNA editing tools
- Growing investments in R&D of DNA modifying agents
- Increasing awareness about the benefits of precision medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
DNA Modifying Agents Market Research Report
By Type
Cross-linkers, Enzymes
By Application
Genomic Research, Gene Therapy, Cancer Research, Drug development, Others
By Companies
Thermo Fisher Scientific, Promega Corporation, Merck, Takara Bio, Bio-Rad Laboratories, Gene Link, New England Biolabs, NZYTech, Lucigen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global DNA Modifying Agents Market Report Segments:
The global DNA Modifying Agents market is segmented on the basis of:
Types
Cross-linkers, Enzymes
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Genomic Research, Gene Therapy, Cancer Research, Drug development, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Promega Corporation
- Merck
- Takara Bio
- Bio-Rad Laboratories
- Gene Link
- New England Biolabs
- NZYTech
- Lucigen
Highlights of The DNA Modifying Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cross-linkers
- Enzymes
- By Application:
- Genomic Research
- Gene Therapy
- Cancer Research
- Drug development
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DNA Modifying Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DNA modifying agents are chemicals that can be used to change the genetic makeup of cells. This can be done in a number of ways, including by using enzymes or other chemical methods.
Some of the major companies in the dna modifying agents market are Thermo Fisher Scientific, Promega Corporation, Merck, Takara Bio, Bio-Rad Laboratories, Gene Link, New England Biolabs, NZYTech, Lucigen.
The dna modifying agents market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 DNA Modifying Agents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 DNA Modifying Agents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 DNA Modifying Agents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the DNA Modifying Agents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global DNA Modifying Agents Market Size & Forecast, 2020-2028
4.5.1 DNA Modifying Agents Market Size and Y-o-Y Growth
4.5.2 DNA Modifying Agents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cross-linkers
5.2.2 Enzymes
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Genomic Research
6.2.2 Gene Therapy
6.2.3 Cancer Research
6.2.4 Drug development
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global DNA Modifying Agents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 DNA Modifying Agents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cross-linkers
9.6.2 Enzymes
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Genomic Research
9.10.2 Gene Therapy
9.10.3 Cancer Research
9.10.4 Drug development
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cross-linkers
10.6.2 Enzymes
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Genomic Research
10.10.2 Gene Therapy
10.10.3 Cancer Research
10.10.4 Drug development
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cross-linkers
11.6.2 Enzymes
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Genomic Research
11.10.2 Gene Therapy
11.10.3 Cancer Research
11.10.4 Drug development
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cross-linkers
12.6.2 Enzymes
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Genomic Research
12.10.2 Gene Therapy
12.10.3 Cancer Research
12.10.4 Drug development
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cross-linkers
13.6.2 Enzymes
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Genomic Research
13.10.2 Gene Therapy
13.10.3 Cancer Research
13.10.4 Drug development
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 DNA Modifying Agents Market: Competitive Dashboard
14.2 Global DNA Modifying Agents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Promega Corporation
14.3.3 Merck
14.3.4 Takara Bio
14.3.5 Bio-Rad Laboratories
14.3.6 Gene Link
14.3.7 New England Biolabs
14.3.8 NZYTech
14.3.9 Lucigen
